These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 15149777
21. Influenza vaccination in patients with breast cancer: a case-series analysis. Vilar-Compte D, Cornejo P, Valle-Salinas A, Roldán-Marin R, Iguala M, Cervantes Y, López I. Med Sci Monit; 2006 Aug; 12(8):CR332-6. PubMed ID: 16865064 [Abstract] [Full Text] [Related]
22. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. J Infect Dis; 1999 Jan; 179(1):31-6. PubMed ID: 9841819 [Abstract] [Full Text] [Related]
23. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. Brokstad KA, Eriksson JC, Cox RJ, Tynning T, Olofsson J, Jonsson R, Davidsson A. J Infect Dis; 2002 Apr 01; 185(7):878-84. PubMed ID: 11920311 [Abstract] [Full Text] [Related]
24. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003). Michiels B, Philips H, Coenen S, Denekens J, Van Royen P. Vaccine; 2006 Apr 12; 24(16):3145-52. PubMed ID: 16490288 [Abstract] [Full Text] [Related]
25. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines]. Baldo V, Menegon T, Buoro S, Scalici C, Vesco A, Perale S, Boato W, Carletti M, Bonello C, Dalla Costa D, Trivello R. Ann Ig; 1999 Apr 12; 11(5):369-74. PubMed ID: 10596424 [No Abstract] [Full Text] [Related]
26. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M. J Med Virol; 2001 Nov 12; 65(3):584-9. PubMed ID: 11596097 [Abstract] [Full Text] [Related]
27. Influenza immunisation in children with solid tumours. Chisholm J, Howe K, Taj M, Zambon M. Eur J Cancer; 2005 Oct 12; 41(15):2280-7. PubMed ID: 16143516 [Abstract] [Full Text] [Related]
28. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study. Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M. Rheumatology (Oxford); 2009 Oct 12; 48(10):1294-9. PubMed ID: 19692457 [Abstract] [Full Text] [Related]
29. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older. Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC. Vaccine; 2011 May 09; 29(20):3633-9. PubMed ID: 21440036 [Abstract] [Full Text] [Related]
30. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Stiver HG, Weinerman BH. Can Med Assoc J; 1978 Oct 07; 119(7):733,-5, 738. PubMed ID: 709474 [Abstract] [Full Text] [Related]
31. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z. Vaccine; 2004 Jun 30; 22(20):2566-77. PubMed ID: 15193382 [Abstract] [Full Text] [Related]
32. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland]. Brydak L, Rudnicka H. Przegl Epidemiol; 1993 Jun 30; 47(3):275-83. PubMed ID: 8234846 [Abstract] [Full Text] [Related]
34. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Camilloni B, Neri M, Lepri E, Iorio AM. Vaccine; 2009 Jun 24; 27(31):4099-103. PubMed ID: 19410623 [Abstract] [Full Text] [Related]
35. Efficacy of influenza vaccination in adult liver transplant recipients. Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus AD. J Med Virol; 2000 May 24; 61(1):85-93. PubMed ID: 10745238 [Abstract] [Full Text] [Related]
36. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. Zeman AM, Holmes TH, Stamatis S, Tu W, He XS, Bouvier N, Kemble G, Greenberg HB, Lewis DB, Arvin AM, Dekker CL. Pediatr Infect Dis J; 2007 Feb 24; 26(2):107-15. PubMed ID: 17259871 [Abstract] [Full Text] [Related]
37. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season]. Lupulescu E, Ioniţă E, Botez D, Matepciuc M, Tabra ME, Tecu C, Alexandrescu V, Munţiu A. Bacteriol Virusol Parazitol Epidemiol; 1997 Feb 24; 42(1-2):110-2. PubMed ID: 9235136 [No Abstract] [Full Text] [Related]
38. Pregnancy modifies the antibody response to trivalent influenza immunization. Schlaudecker EP, McNeal MM, Dodd CN, Ranz JB, Steinhoff MC. J Infect Dis; 2012 Dec 01; 206(11):1670-3. PubMed ID: 22984116 [Abstract] [Full Text] [Related]
39. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D. J Infect Dis; 2006 Oct 15; 194(8):1032-9. PubMed ID: 16991077 [Abstract] [Full Text] [Related]
40. [Influenza live attenuated intra-nasal vaccines]. Weil-Olivier C. Arch Pediatr; 2010 Jun 15; 17(6):904-5. PubMed ID: 20654953 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]